Fund Card

Fund Card

Nippon India Pharma Fund(G)

As on Nov-21-2019 change fund
150.60  down-0.85 (-0.56%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2014-20152015-20162016-20172017-20182018-2019
NAV in Rs (as on 31-Mar-2019)137.59131.24135.25133.66151.74
Net Assets(Rs Crores) (as on 31-Mar-2019) 1261.95 1408.45 1444.86 1875.94 2687.68
Scheme Returns(%)(Absolute)57.02-6.323.13-2.1113.53
B'mark Returns(%)(Absolute)71.42-13.741.71-14.457.46
Category Rank11/5919/5848/5651/629/73
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2019-2020-6.50-1.11NANA
2018-20196.9510.70-5.501.47
2017-2018-4.950.1912.03-7.37
2016-20172.177.77-7.220.87
2015-2016-2.6414.72-2.43-12.47
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...11.60 
Divis Laboratories Ltd.10.11 
Cipla Ltd.9.03 
Dr. Reddys Laboratories Ltd.7.45 
Abbott India Ltd.7.12 
Lupin Ltd.7.05 
Fortis Healthcare Ltd.6.89 
Syngene International Ltd.6.64 
Aurobindo Pharma Ltd.5.74 
Alkem Laboratories Ltd.5.55 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

2,429.66

portfolio price to book value

4.49

investing style?

Mid Growth

fund manager?

Sailesh Raj Bhan,Kinjal Desai

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

2.20

Alpha [%]

-0.04

Beta [%]

0.50

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs78.93
Hospital & Healthcare Services13.95
Miscellaneous7.15

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Mid-Growth 05-Jun-20042,429.663.485.6610.21-1.853.063.9014.6719.16BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-2015173.633.543.967.243.581.32NANA-2.04BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005392.784.376.439.79-1.46-1.25-0.1311.3816.02BUYSIP
SBI Healthcare Opp Fund-Reg(G)Mid-Growth 14-Jul-1999936.913.057.1810.19-3.26-4.010.2013.4413.81BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Mid-Growth 02-Jul-2018357.923.264.908.792.34NANANA5.31BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20181,339.102.015.398.431.09NANANA1.17BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018235.172.215.7210.40NANANANA7.18BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Mid-Growth 10-Jul-2019170.533.423.226.22NANANANA5.80BUYSIP
IDBI Healthcare Fund-Reg(G)Mid-Growth 28-Feb-201933.173.145.529.02NANANANA5.10BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974